NASDAQ:DARA (DARA) (DARA) Stock Price, News & Analysis → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free DARA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range$0.32▼$0.3352-Week Range N/AVolume13,850 shsAverage Volume118,843 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (DARA) alerts: Email Address Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> About (DARA) Stock (NASDAQ:DARA)DARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company’s primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy. The Company is a subsidiary of Midatech Pharma Plc.Read More Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> DARA Stock News HeadlinesMarch 27, 2024 | msn.comWinners announced in Intercounty Electric’s essay contestMarch 25, 2024 | msn.comDara O’Shea: We need an Irish manager who understands our gameMarch 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 25, 2024 | msn.comDara O'Shea: “Us as a group, we just want somebody who understands Irish football and who knows what it is"March 25, 2024 | msn.comThis Samsonite Carry-on Is Frequent Flier-approvedMarch 24, 2024 | msn.com'The more, the merrier!' Mother of Princess Beatrice's stepson says she is still close with her ex-fiance and is happy her child has 'two sets of parents trying to help him'March 23, 2024 | msn.comSoccer-Ferguson fluffs penalty as Ireland draw with BelgiumMarch 22, 2024 | msn.comHow Oso slide changed local emergency response ‘on virtually every level’March 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 21, 2024 | msn.com'Dara Hua Tanashah': How INDIA Bloc Reacted To Arvind Kejriwal's ArrestMarch 21, 2024 | msn.comSEL teaches kids to deal with their emotions. It's under attack as 'woke' indoctrination.March 20, 2024 | cnn.comMacKenzie Scott dará US$ 640 millones a varias organizacionesMarch 19, 2024 | msn.comThePrint journalist wins Ramnath Goenka award for report on tomb of Shah Jahan’s son Dara ShukohMarch 18, 2024 | msn.com‘I’m buzzing now’ – Dara O’Shea upbeat for Ireland duty after rare Premier League win for BurnleyMarch 15, 2024 | msn.comCalligraphers learn to copy Qur'an in Ottoman script at Dara workshopMarch 13, 2024 | chron.comEEUU dará $300 millones en armas a Ucrania pese a escasez de fondosMarch 13, 2024 | msn.comDid you know Dara Singh was unsure about playing Lord Hanuman in 'Ramayan' due to THIS reason? Vindu Dara Singh reveals...March 12, 2024 | msn.comUP CM Yogi Adityanath Allocates Portfolio To Rajbhar, Dara Singh, Other MinistersMarch 12, 2024 | msn.comCM Yogi allots portfolios to newly inducted ministers in UP CabinetMarch 11, 2024 | fortune.comDara A. BuschMarch 11, 2024 | theguardian.comCarlo Rovelli in conversation with Dara Ó BriainMarch 10, 2024 | msn.comVindu Dara Singh calls Prabhas-Kriti Sanon's Adipurush 'huge mistake'; says makers were asked to 'change dialogues'March 10, 2024 | msn.comVindu Dara Singh calls Adipursh a 'mistake'; reveals actors questioned Om Raut about the dialogues on the setsMarch 8, 2024 | msn.comSalman Khan still runs on the pocket money his father gives and helps people with it, reveals Vindu Dara SinghMarch 8, 2024 | msn.comUber CEO Dara Khosrowshahi on its ride-hailing business, India strategyMarch 8, 2024 | msn.comDid you know Dara Singh's family was popping champagne after his demise? Here's how Amitabh Bachchan reacted!March 6, 2024 | msn.comUttar Pradesh: BJP Bolsters Support Base In Purvanchal With Induction Of Om Prakash Rajbhar & Dara Singh Chauhan In MinistrySee More Headlines Receive DARA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (DARA) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2015Today3/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:DARA CUSIPN/A CIK919745 Webwww.darabiosciences.com Phone+1-816-9147027FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report DARA Stock Analysis - Frequently Asked Questions How were (DARA)'s earnings last quarter? (DARA) (NASDAQ:DARA) posted its earnings results on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) EPS for the quarter, meeting the consensus estimate of ($0.14). The specialty pharmaceutical company had revenue of $1.18 million for the quarter, compared to the consensus estimate of $0.83 million. What other stocks do shareholders of (DARA) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (DARA) investors own include Castleton Technology (CTP), Richland Resources Ltd (RLD.L) (RLD), Thor Energy (THR), Global Invacom Group (GINV), Legendary Investments (LEG), iPass (IPAS), Aeterna Zentaris (AEZS), Clontarf Energy (CLON) and MoSys (MOSY). This page (NASDAQ:DARA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill PublishingThe 3rd Revolution in WarfareWeiss RatingsBill Ackman’s 2024 warningPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (DARA) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.